Coya Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $8.3M | — |
| FY2021 | — | $3.6M | $4.3M |
| FY2022 | — | $-8.4M | $5.9M |
| FY2023 | — | $35.6M | $32.6M |
| FY2024 | — | $39.6M | $38.3M |
| FY2025 | — | $43.0M | $46.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $8.3M | — |
| FY2021 | — | $3.6M | $4.3M |
| FY2022 | — | $-8.4M | $5.9M |
| FY2023 | — | $35.6M | $32.6M |
| FY2024 | — | $39.6M | $38.3M |
| FY2025 | — | $43.0M | $46.8M |